Rigel Pharmaceuticals Inc · Other Income/Expenses (Net)

RIGL Other Income/Expenses (Net)

Latest reported-$1.47Mperiod endingJun 30, 2026

RIGL TTM Other Income/Expenses (Net) ($145.00K → -$1.47M)

TTM Other Income/Expenses (Net)

High-resolution chart · PNG

RIGL other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Rigel Pharmaceuticals Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period ending	Other Income/Expenses (Net) (USD)
Jun 30, 2026	-1,474,000
Mar 31, 2026	-2,605,000
Dec 31, 2025	-3,639,000
Sep 30, 2025	-4,616,000
Jun 30, 2025	-5,451,000
Mar 31, 2025	-5,807,000
Dec 31, 2024	-5,826,000
Sep 30, 2024	-5,622,000
Jun 30, 2024	-5,214,000
Mar 31, 2024	-5,070,000
Dec 31, 2023	-4,600,000
Sep 30, 2023	-4,049,000
Jun 30, 2023	-3,456,000
Mar 31, 2023	-2,650,000
Dec 31, 2022	-3,023,000
Sep 30, 2022	-3,628,000
Jun 30, 2022	-4,297,000
Mar 31, 2022	-5,513,000
Dec 31, 2021	-4,813,000
Sep 30, 2021	-3,940,000
Jun 30, 2021	-3,030,000
Mar 31, 2021	-1,471,000
Dec 31, 2020	-771,000
Sep 30, 2020	-224,000
Jun 30, 2020	716,000
Mar 31, 2020	1,633,000
Dec 31, 2019	2,197,000
Sep 30, 2019	2,756,000
Jun 30, 2019	2,813,000
Mar 31, 2019	2,634,000
Dec 31, 2018	2,203,000
Sep 30, 2018	1,851,000
Jun 30, 2018	1,442,000
Mar 31, 2018	1,085,000
Dec 31, 2017	1,624,000
Sep 30, 2017	1,477,000
Jun 30, 2017	1,392,000
Mar 31, 2017	1,310,000
Dec 31, 2016	525,000
Sep 30, 2016	388,000
Jun 30, 2016	387,000
Mar 31, 2016	334,000
Dec 31, 2015	279,000
Sep 30, 2015	315,000
Jun 30, 2015	304,000
Mar 31, 2015	307,000
Dec 31, 2014	341,000
Sep 30, 2014	328,000
Jun 30, 2014	336,000
Mar 31, 2014	388,000
Dec 31, 2013	442,000
Sep 30, 2013	-72,865,000
Jun 30, 2013	-72,858,000
Mar 31, 2013	-72,831,000
Dec 31, 2012	-72,831,000
Sep 30, 2012	516,000
Jun 30, 2012	513,000
Mar 31, 2012	452,000
Dec 31, 2011	395,000
Sep 30, 2011	2,702,000
Jun 30, 2011	2,667,000
Mar 31, 2011	2,635,000
Dec 31, 2010	2,573,000
Sep 30, 2010	152,000
Jun 30, 2010	81,000
Mar 31, 2010	120,000
Dec 31, 2009	397,000
Sep 30, 2009	-3,334,000
Jun 30, 2009	-2,347,000
Mar 31, 2009	-1,189,000
Dec 31, 2008	0
Sep 30, 2008	-50,293,000
Jun 30, 2008	-49,802,000
Mar 31, 2008	-49,689,000
Dec 31, 2007	-50,015,000
Sep 30, 2007	-16,743,000
Jun 30, 2007	-16,880,000
Mar 31, 2007	-16,962,000
Dec 31, 2006	-16,771,000
Sep 30, 2006	-31,198,000
Jun 30, 2006	-31,672,000
Mar 31, 2006	-32,614,000
Dec 31, 2005	-33,697,000
Sep 30, 2005	16,375,000
Jun 30, 2005	15,686,000
Mar 31, 2005	15,534,000
Dec 31, 2004	15,338,000
Sep 30, 2004	-28,889,000
Jun 30, 2004	-29,093,000
Mar 31, 2004	-29,383,000
Dec 31, 2003	-29,705,000
Sep 30, 2003	-29,422,000
Jun 30, 2003	-29,441,000
Mar 31, 2003	-29,292,000
Dec 31, 2002	-28,974,000
Sep 30, 2002	-17,534,000
Jun 30, 2002	-17,296,000
Mar 31, 2002	-17,058,000
Dec 31, 2001	-16,539,000
Sep 30, 2001	11,216,000